News

ERA-EDTA, May 24-27, Paris, France May 08 2012

BioPorto Diagnostics Product overview 2012 March 02 2012

ISICEM 2012, March 20-23, Brussels, Belgium February 23 2012

CRITICARE, February 15-19, Pune, India January 24 2012

Conference on Continuous Renal Replacement Therapies (CRRT), February 12-15, San Diego, USA January 24 2012

MEDLAB, Arab Health, January 23-26, Dubai, UAE January 16 2012

An addition to the Obesity and Type 2 Diabetes antibody portfolio December 22 2011

Better kidney markers ahead? December 05 2011

New NGAL.com website launched November 24 2011

MEDICA, November 16-19, Düsseldorf, Germany October 26 2011

next 10

MEDICA, November 16-19, Düsseldorf, Germany

October 26 2011 by BioPorto Diagnostics

The world’s largest medical trade fair, MEDICA, introduces a wide variety of innovations and know-how in the world of healthcare.

BioPorto Diagnostics will be represented at MEDICA, promoting The NGAL Test™, designed for measuring the emerging biomarker NGAL.

What is NGAL?

NGAL is a biomarker for diagnosing acute kidney injury (AKI). The biomarker has been recognised by the market as a new way to identify patients at risk of developing potentially severe acute kidney injury (AKI).

Meet BioPorto Diagnostics representatives at stand K88, Hall 3, or contact us prior to the congress for an appointment at info@bioporto.com

For further information on MEDICA, please click here